KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Amneal Pharmaceuticals (AMRX) Return on Invested Capital: 2018-2025

Historic Return on Invested Capital for Amneal Pharmaceuticals (AMRX) over the last 2 years, with Sep 2025 value amounting to 0.13%.

  • Amneal Pharmaceuticals' Return on Invested Capital was N/A to 0.13% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.13%, marking a year-over-year change of. This contributed to the annual value of 0.03% for FY2021, which is N/A change from last year.
  • Latest data reveals that Amneal Pharmaceuticals reported Return on Invested Capital of 0.13% as of Q3 2025, which was up 26.50% from 0.10% recorded in Q2 2025.
  • In the past 5 years, Amneal Pharmaceuticals' Return on Invested Capital registered a high of 0.30% during Q3 2021, and its lowest value of 0.05% during Q2 2023.
  • In the last 2 years, Amneal Pharmaceuticals' Return on Invested Capital had a median value of 0.10% in 2025 and averaged 0.10%.